Ledger.Open graph →
SEC Form D · filed December 29, 2014

Ohr Pharmaceutical Inc

Offering
$50K
Sold
$50K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Orin Hirschman · New York, NYDirectorSam Backenroth · New York, NYExecThomas Riedhammer · New York, NYDirectorIra Greenstein · New York, NYDirectorJune Almenoff · New York, NYDirectorIrach Taraporewala · New York, NYExec · DirectorArlene Coyle · SEATTLE, WADirectorSteve Heaps · SEATTLE, WADirectorMatt Hulett · SEATTLE, WADirectorWilliam Mcaleer · SEATTLE, WADirectorJames Filsinger · SEATTLE, WAExec · DirectorR. S. Macphee · Boston, MAExec · DirectorRobert E. Howard Iv · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗